In addition, we show that APR-246 can overcome hypoxia-induced cisplatin resistance in an ROS-dependent and mutant p53Q331*-dependent manner through GSH depletion rather than reactivation of mutant p53 in the NCI-H2228 NSCLC cell line. This evidence concerns the gene TP53 and non-small cell lung carcinoma.